Skip to main content
FDA approval - fezolinetant
News

FDA approves migraine med

Zavzpret (zavegepant) is a new fast-acting treatment option
FDA approval - fezolinetant
News

FDA approves Symbicort generic

Now there’s another, more affordable option to treat these two common respiratory conditions
Paxlovid
News

Paxlovid 101

It’s the first oral treatment for COVID-19, and could be a pandemic game-changer
Evusheld shot for COVID-19 prevention:
News

New med Evusheld could prevent COVID

A new preventive medication was approved for people who aren’t protected by the vaccine
FDA approval - fezolinetant
News

FDA approves Humira alternative

The new medication can be prescribed to people with several inflammatory diseases
FDA approval stamp
News

Meet Ubrelvy, the new FDA-approved medication that cures migraine

In nearly 1 in 4 U.S. households, someone suffers from migraine, according…
FDA approval stamp
News

FDA approves first insulin biosimilar

There’s now another option for people with Type 1 and Type 2 diabetes—one that could save a lot of money
A stamp for FDA approval - naloxone OTC
News

FDA approves OTC switch for Astepro

This non-steroidal nasal spray is good news for the 60 million people in the U.S. living with allergies
FDA approval stamp
News

FDA approves Alzheimer’s drug

It’s the first new medication for this condition since 2003
A stamp for FDA approval - naloxone OTC
News

FDA approves multiple sclerosis treatment Ocrevus

Until 1993, when interferon beta-1b was approved as the first therapy, there…
FDA approval - fezolinetant
News

FDA approves Trijardy XR for type 2 diabetes

Good news for adults with type 2 diabetes: You have a new…